Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Ongoing research exploring mechanisms of resistance to IMiDs in myeloma

Lawrence Boise, PhD, Winship Cancer Institute of Emory University, Atlanta, GA, briefly discusses research exploring mechanisms of resistance to agents including lenalidomide, pomalidomide, and thalidomide, highlighting the role of the Ikaros protein. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.